Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
OCGN Stock — Ocugen, Inc.
Ocugen, Inc. (OCGN)
Updated October 16, 2026.
OCGN is a Stock. Total return is -99.9% over the past 11.9 years, 447.9 points behind SPY at 348.0%.
Ocugen is a biopharmaceutical company developing gene and cell therapies, biologics, and vaccines targeting eye diseases and infectious diseases. The company's lead programs include OCU400, a gene therapy in Phase 3 trials for retinitis pigmentosa, along with earlier-stage candidates for age-related macular degeneration, Stargardt disease, and diabetic eye conditions, plus vaccine candidates for COVID-19 and influenza. The company does not currently distribute to shareholders.
OCGN dividend yield and income
Price as of 2026-10-16.
The payment date is 09/30/2019.
OCGN performance versus SPY
Price and return data through 2026-10-16.
Total return is -99.9% over the past 11.9 years, 447.9 points behind SPY at 348.0%. Over the past year its total return — price change plus distributions reinvested — is -51.5%. Its deepest 1-year drawdown was 68.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -21.8% | — |
| 3M | -43.0% | — |
| 6M | -59.6% | — |
| YTD | -42.2% | — |
| 1Y | -51.5% | — |
| 2Y CAGR | — | -8.80% |
| 3Y CAGR | — | 21.70% |
| 5Y CAGR | — | -38.20% |
| 10Y CAGR | — | -41.60% |
| Since inception (11.9 years) | -99.9% | -43.60% |
OCGN key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 12/03/2014
- Distribution frequency
- None
- Last close
- $0.78 (as of 2026-10-16)
- Market cap
- $264,607,846
- Average volume
- 5129306.0
- Payment date
- 09/30/2019
- Beta
- 2.268
- Payout ratio
- 0.0%
- Forward P/E
- 13.0719
- EPS
- $-0.24
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
OCGN risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 68.5%.
Who may consider OCGN — and who may not
It is a weaker fit for investors who need monthly cash flow (OCGN does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on OCGN
Frequently asked questions
Does OCGN pay monthly?
No. OCGN does not currently distribute.
When does OCGN pay a dividend?
OCGN does not currently distribute. The payment date is 09/30/2019.
How has OCGN performed?
Total return is -99.9% over the past 11.9 years, 447.9 points behind SPY at 348.0%. Over the past year its total return — price change plus distributions reinvested — is -51.5%. Its deepest 1-year drawdown was 68.5%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.